These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 21480394)
1. OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer. Gazouli M; Roubelakis MG; Theodoropoulos GE; Papailiou J; Vaiopoulou A; Pappa KI; Nikiteas N; Anagnou NP Mol Carcinog; 2012 Feb; 51(2):165-73. PubMed ID: 21480394 [TBL] [Abstract][Full Text] [Related]
2. Oct4, a novel marker for human gastric cancer. Chen Z; Xu WR; Qian H; Zhu W; Bu XF; Wang S; Yan YM; Mao F; Gu HB; Cao HL; Xu XJ J Surg Oncol; 2009 Jun; 99(7):414-9. PubMed ID: 19347886 [TBL] [Abstract][Full Text] [Related]
3. OCT4B1, a novel spliced variant of OCT4, generates a stable truncated protein with a potential role in stress response. Farashahi Yazd E; Rafiee MR; Soleimani M; Tavallaei M; Salmani MK; Mowla SJ Cancer Lett; 2011 Oct; 309(2):170-5. PubMed ID: 21684074 [TBL] [Abstract][Full Text] [Related]
4. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma. Zhao S; Yuan Q; Hao H; Guo Y; Liu S; Zhang Y; Wang J; Liu H; Wang F; Liu K; Ling EA; Hao A J Pathol; 2011 Apr; 223(5):672-82. PubMed ID: 21341266 [TBL] [Abstract][Full Text] [Related]
5. The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B. Gao Y; Wang X; Han J; Xiao Z; Chen B; Su G; Dai J J Genet Genomics; 2010 Jul; 37(7):461-5. PubMed ID: 20659710 [TBL] [Abstract][Full Text] [Related]
6. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor. Asadi MH; Mowla SJ; Fathi F; Aleyasin A; Asadzadeh J; Atlasi Y Int J Cancer; 2011 Jun; 128(11):2645-52. PubMed ID: 20824712 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer. Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223 [TBL] [Abstract][Full Text] [Related]
8. Identification and differential expression patterns of porcine OCT4 variants. Hwang JY; Oh JN; Lee DK; Choi KH; Park CH; Lee CK Reproduction; 2015 Jan; 149(1):55-66. PubMed ID: 25342174 [TBL] [Abstract][Full Text] [Related]
9. OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells. Asadi MH; Khalifeh K; Mowla SJ J Neurooncol; 2016 Dec; 130(3):455-463. PubMed ID: 27585657 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770 [TBL] [Abstract][Full Text] [Related]
11. Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status. Chu D; Zheng J; Wang W; Zhao Q; Li Y; Li J; Xie H; Zhang H; Dong G; Xu C; Li M; Chen D; Ji G Ann Surg Oncol; 2009 Dec; 16(12):3259-66. PubMed ID: 19653042 [TBL] [Abstract][Full Text] [Related]
12. Oct4 and Sox2 are overexpressed in human neuroblastoma and inhibited by chemotherapy. Yang S; Zheng J; Ma Y; Zhu H; Xu T; Dong K; Xiao X Oncol Rep; 2012 Jul; 28(1):186-92. PubMed ID: 22576801 [TBL] [Abstract][Full Text] [Related]
13. Oct4 expression in in-vitro-produced sheep blastocysts and embryonic-stem-like cells. Sanna D; Sanna A; Mara L; Pilichi S; Mastinu A; Chessa F; Pani L; Dattena M Cell Biol Int; 2009 Dec; 34(1):53-60. PubMed ID: 19947952 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis. Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977 [TBL] [Abstract][Full Text] [Related]
15. [Expression and single nucleotide polymorphisms of kallikrein 10 in colorectal cancer]. Feng B; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Qu Y; Li JW; Lu AG; Wang ML; Liu BY; Zhu ZG Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):623-7. PubMed ID: 16784657 [TBL] [Abstract][Full Text] [Related]
16. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989 [TBL] [Abstract][Full Text] [Related]
17. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer. Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967 [TBL] [Abstract][Full Text] [Related]
18. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739 [TBL] [Abstract][Full Text] [Related]
19. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Liedtke S; Stephan M; Kögler G Biol Chem; 2008 Jul; 389(7):845-50. PubMed ID: 18627312 [TBL] [Abstract][Full Text] [Related]
20. A plausible anti-apoptotic role of up-regulated OCT4B1 in bladder tumors. Asadzadeh J; Asadi MH; Shakhssalim N; Rafiee MR; Kalhor HR; Tavallaei M; Mowla SJ Urol J; 2012; 9(3):574-80. PubMed ID: 22903480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]